|
2012-09-06 |
2012-09-05 |
A
Achat
|
SPECTRUM PHARMACEUTICALS INC
Actionnaire important
|
130 854 840
+100.0%
1,82
238 155 809 USD
|
130 854 840
+100.0%
|
1,82
|
238 155 809 USD
|
|
|
2012-03-01 |
2012-03-01 |
VP
Vente planifiée
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Dirigeant
|
3 025
-2.0%
1,50
4 522 USD
|
3 025
-2.0%
|
1,50
|
4 522 USD
|
|
|
2012-03-01 |
2012-02-29 |
VP
Vente planifiée
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Dirigeant
|
3 031
-2.0%
1,53
4 623 USD
|
3 031
-2.0%
|
1,53
|
4 623 USD
|
|
|
2012-02-27 |
2012-02-24 |
VP
Vente planifiée
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Dirigeant
|
1 469
-1.3%
1,55
2 277 USD
|
1 469
-1.3%
|
1,55
|
2 277 USD
|
|
|
2011-02-25 |
2011-02-24 |
VP
Vente planifiée
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Dirigeant
|
1 469
-1.5%
3,20
4 701 USD
|
1 469
-1.5%
|
3,20
|
4 701 USD
|
|
|
2010-05-12 |
2010-05-10 |
VP
Vente planifiée
|
Clark David C
VP, Finance
Dirigeant
|
3 085
-15.3%
7,03
21 684 USD
|
3 085
-15.3%
|
7,03
|
21 684 USD
|
|
|
2010-04-14 |
2010-04-12 |
VP
Vente planifiée
|
Graboyes Marc H
SVP, General Counsel
Dirigeant
|
75 000
-56.4%
8,58
643 530 USD
|
75 000
-56.4%
|
8,58
|
643 530 USD
|
|
|
2010-03-12 |
2010-03-10 |
VP
Vente planifiée
|
Clark David C
VP, Finance
Dirigeant
|
20 000
-50.8%
7,78
155 612 USD
|
20 000
-50.8%
|
7,78
|
155 612 USD
|
|
|
2010-03-08 |
2010-03-05 |
VP
Vente planifiée
|
Clark David C
VP, Finance
Dirigeant
|
10 000
-34.1%
7,02
70 196 USD
|
10 000
-34.1%
|
7,02
|
70 196 USD
|
|
|
2010-03-08 |
2010-03-04 |
VP
Vente planifiée
|
Clark David C
VP, Finance
Dirigeant
|
11 640
-37.6%
6,98
81 301 USD
|
11 640
-37.6%
|
6,98
|
81 301 USD
|
|
|
2010-03-03 |
2010-03-01 |
VP
Vente planifiée
|
CARUSO JAMES V
Chief Commercial Officer
Dirigeant
|
37 500
-26.6%
8,13
304 875 USD
|
37 500
-26.6%
|
8,13
|
304 875 USD
|
|
|
2010-03-03 |
2010-03-01 |
VP
Vente planifiée
|
CARUSO JAMES V
Chief Commercial Officer
Dirigeant
|
40 000
-22.1%
8,13
325 204 USD
|
40 000
-22.1%
|
8,13
|
325 204 USD
|
|
|
2010-02-24 |
2010-02-24 |
VP
Vente planifiée
|
BERNS PAUL L
Chief Executive Officer
Dirigeant
|
7 362
-3.2%
7,57
55 766 USD
|
7 362
-3.2%
|
7,57
|
55 766 USD
|
|
|
2010-02-24 |
2010-02-24 |
VP
Vente planifiée
|
Graboyes Marc H
SVP, General Counsel
Dirigeant
|
2 349
-3.9%
7,44
17 477 USD
|
2 349
-3.9%
|
7,44
|
17 477 USD
|
|
|
2010-02-24 |
2010-02-23 |
VP
Vente planifiée
|
BERNS PAUL L
Chief Executive Officer
Dirigeant
|
4 304
-1.8%
7,51
32 331 USD
|
4 304
-1.8%
|
7,51
|
32 331 USD
|
|
|
2010-02-24 |
2010-02-23 |
VP
Vente planifiée
|
CARUSO JAMES V
Chief Commercial Officer
Dirigeant
|
5 968
-4.1%
7,44
44 378 USD
|
5 968
-4.1%
|
7,44
|
44 378 USD
|
|
|
2010-02-24 |
2010-02-23 |
VP
Vente planifiée
|
Graboyes Marc H
SVP, General Counsel
Dirigeant
|
1 416
-2.3%
7,51
10 634 USD
|
1 416
-2.3%
|
7,51
|
10 634 USD
|
|
|
2010-02-24 |
2010-02-23 |
VP
Vente planifiée
|
BENNETT BRUCE K JR
VP, Pharmaceutical Operations
Dirigeant
|
1 468
-6.0%
7,51
11 025 USD
|
1 468
-6.0%
|
7,51
|
11 025 USD
|
|
|
2010-01-11 |
2010-01-11 |
VP
Vente planifiée
|
HOFFMAN STEPHEN J
Administrateur non-exécutif
|
45 428
-8.7%
7,30
331 738 USD
|
45 428
-8.7%
|
7,30
|
331 738 USD
|
|
|
2010-01-11 |
2010-01-08 |
VP
Vente planifiée
|
HOFFMAN STEPHEN J
Administrateur non-exécutif
|
45 429
-8.7%
7,11
322 918 USD
|
45 429
-8.7%
|
7,11
|
322 918 USD
|
|
|
2010-01-11 |
2010-01-07 |
VP
Vente planifiée
|
HOFFMAN STEPHEN J
Administrateur non-exécutif
|
45 429
-8.7%
6,76
307 114 USD
|
45 429
-8.7%
|
6,76
|
307 114 USD
|
|
|
2010-01-06 |
2010-01-06 |
VP
Vente planifiée
|
HOFFMAN STEPHEN J
Administrateur non-exécutif
|
45 429
-8.7%
6,78
308 163 USD
|
45 429
-8.7%
|
6,78
|
308 163 USD
|
|
|
2010-01-06 |
2010-01-05 |
VP
Vente planifiée
|
HOFFMAN STEPHEN J
Administrateur non-exécutif
|
45 428
-8.7%
6,64
301 497 USD
|
45 428
-8.7%
|
6,64
|
301 497 USD
|
|
|
2010-01-06 |
2010-01-04 |
VP
Vente planifiée
|
HOFFMAN STEPHEN J
Administrateur non-exécutif
|
25 428
-5.1%
6,54
166 220 USD
|
25 428
-5.1%
|
6,54
|
166 220 USD
|
|
|
2009-08-12 |
2009-08-10 |
VP
Vente planifiée
|
CARUSO JAMES V
Chief Commercial Officer
Dirigeant
|
85 400
-49.0%
8,13
694 302 USD
|
85 400
-49.0%
|
8,13
|
694 302 USD
|
|
|
2009-08-12 |
2009-08-10 |
VP
Vente planifiée
|
BERNS PAUL L
Chief Executive Officer
Dirigeant
|
342 000
-59.6%
8,24
2 819 311 USD
|
342 000
-59.6%
|
8,24
|
2 819 311 USD
|
|
|
2009-08-07 |
2009-08-05 |
VP
Vente planifiée
|
BERNS PAUL L
Chief Executive Officer
Dirigeant
|
8 000
-3.3%
8,14
65 150 USD
|
8 000
-3.3%
|
8,14
|
65 150 USD
|
|
|
2009-08-05 |
2009-08-05 |
VP
Vente planifiée
|
CARUSO JAMES V
Chief Commercial Officer
Dirigeant
|
14 600
-14.1%
8,13
118 755 USD
|
14 600
-14.1%
|
8,13
|
118 755 USD
|
|
|
2009-08-05 |
2009-08-03 |
VP
Vente planifiée
|
Graboyes Marc H
VP, General Counsel
Dirigeant
|
50 000
-71.4%
8,00
400 000 USD
|
50 000
-71.4%
|
8,00
|
400 000 USD
|
|
|
2009-08-05 |
2009-08-03 |
VP
Vente planifiée
|
CARUSO JAMES V
Chief Commercial Officer
Dirigeant
|
50 000
-36.0%
7,79
389 480 USD
|
50 000
-36.0%
|
7,79
|
389 480 USD
|
|
|
2009-03-27 |
2009-03-26 |
VP
Vente planifiée
|
CARUSO JAMES V
Chief Commercial Officer
Dirigeant
|
39 500
-25.3%
7,37
291 206 USD
|
39 500
-25.3%
|
7,37
|
291 206 USD
|
|
|
2009-03-27 |
2009-03-25 |
VP
Vente planifiée
|
CARUSO JAMES V
Chief Commercial Officer
Dirigeant
|
6 900
-5.6%
7,13
49 209 USD
|
6 900
-5.6%
|
7,13
|
49 209 USD
|
|
|
2009-03-16 |
2009-03-16 |
VP
Vente planifiée
|
CARUSO JAMES V
Chief Commercial Officer
Dirigeant
|
3 600
-3.0%
7,13
25 674 USD
|
3 600
-3.0%
|
7,13
|
25 674 USD
|
|
|
2009-03-16 |
2009-03-13 |
VP
Vente planifiée
|
Clark David C
VP, Finance
Dirigeant
|
5 027
-41.3%
7,00
35 189 USD
|
5 027
-41.3%
|
7,00
|
35 189 USD
|
|
|
2009-03-16 |
2009-03-13 |
VP
Vente planifiée
|
Graboyes Marc H
VP, General Counsel
Dirigeant
|
5 864
-22.6%
7,00
41 048 USD
|
5 864
-22.6%
|
7,00
|
41 048 USD
|
|
|
2009-03-16 |
2009-03-12 |
VP
Vente planifiée
|
Clark David C
VP, Finance
Dirigeant
|
64 973
-90.1%
7,02
455 812 USD
|
64 973
-90.1%
|
7,02
|
455 812 USD
|
|
|
2009-03-16 |
2009-03-12 |
VP
Vente planifiée
|
CARUSO JAMES V
Chief Commercial Officer
Dirigeant
|
50 000
-30.1%
7,13
356 500 USD
|
50 000
-30.1%
|
7,13
|
356 500 USD
|
|
|
2009-03-16 |
2009-03-12 |
VP
Vente planifiée
|
Graboyes Marc H
VP, General Counsel
Dirigeant
|
69 136
-77.5%
7,02
485 010 USD
|
69 136
-77.5%
|
7,02
|
485 010 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Vente
|
14159 capital (GP), LLC
Actionnaire important
|
22
-0.0%
8,26
182 USD
|
22
-0.0%
|
8,26
|
182 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Vente
|
14159 capital (GP), LLC
Actionnaire important
|
24 857
-11.5%
8,17
203 176 USD
|
24 857
-11.5%
|
8,17
|
203 176 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Vente
|
BAKER JULIAN
Actionnaire important
|
1
-0.0%
8,26
8 USD
|
1
-0.0%
|
8,26
|
8 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Vente
|
BAKER JULIAN
Actionnaire important
|
705
-11.5%
8,17
5 763 USD
|
705
-11.5%
|
8,17
|
5 763 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Vente
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
235
-0.0%
8,26
1 940 USD
|
235
-0.0%
|
8,26
|
1 940 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Vente
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
263 312
-11.5%
8,17
2 152 260 USD
|
263 312
-11.5%
|
8,17
|
2 152 260 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Vente
|
Baker Bros. Capital (GP), LLC
Actionnaire important
|
212
-11.5%
8,17
1 733 USD
|
212
-11.5%
|
8,17
|
1 733 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Vente
|
Baker / Tisch Capital (GP), LLC
Actionnaire important
|
8
-0.0%
8,26
66 USD
|
8
-0.0%
|
8,26
|
66 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Vente
|
Baker / Tisch Capital (GP), LLC
Actionnaire important
|
9 380
-11.5%
8,17
76 670 USD
|
9 380
-11.5%
|
8,17
|
76 670 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Vente
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
670
-0.0%
8,26
5 532 USD
|
670
-0.0%
|
8,26
|
5 532 USD
|
|
|
2009-02-06 |
2009-02-06 |
V
Vente
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
751 534
-11.5%
8,17
6 142 889 USD
|
751 534
-11.5%
|
8,17
|
6 142 889 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
14159 capital (GP), LLC
Actionnaire important
|
4 725
-2.1%
8,11
38 299 USD
|
4 725
-2.1%
|
8,11
|
38 299 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
14159 capital (GP), LLC
Actionnaire important
|
1 200
-0.5%
8,17
9 806 USD
|
1 200
-0.5%
|
8,17
|
9 806 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
14159 capital (GP), LLC
Actionnaire important
|
6 392
-2.8%
8,16
52 180 USD
|
6 392
-2.8%
|
8,16
|
52 180 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
BAKER JULIAN
Actionnaire important
|
134
-2.1%
8,11
1 086 USD
|
134
-2.1%
|
8,11
|
1 086 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
BAKER JULIAN
Actionnaire important
|
34
-0.5%
8,17
278 USD
|
34
-0.5%
|
8,17
|
278 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
BAKER JULIAN
Actionnaire important
|
181
-2.8%
8,16
1 478 USD
|
181
-2.8%
|
8,16
|
1 478 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
50 041
-2.1%
8,11
405 617 USD
|
50 041
-2.1%
|
8,11
|
405 617 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
12 713
-0.5%
8,17
103 882 USD
|
12 713
-0.5%
|
8,17
|
103 882 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
67 709
-2.8%
8,16
552 729 USD
|
67 709
-2.8%
|
8,16
|
552 729 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
Baker Bros. Capital (GP), LLC
Actionnaire important
|
40
-2.1%
8,11
324 USD
|
40
-2.1%
|
8,11
|
324 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
Baker Bros. Capital (GP), LLC
Actionnaire important
|
10
-0.5%
8,17
82 USD
|
10
-0.5%
|
8,17
|
82 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
Baker Bros. Capital (GP), LLC
Actionnaire important
|
55
-2.8%
8,16
449 USD
|
55
-2.8%
|
8,16
|
449 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
Baker / Tisch Capital (GP), LLC
Actionnaire important
|
1 782
-2.1%
8,11
14 444 USD
|
1 782
-2.1%
|
8,11
|
14 444 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
Baker / Tisch Capital (GP), LLC
Actionnaire important
|
453
-0.5%
8,17
3 702 USD
|
453
-0.5%
|
8,17
|
3 702 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
Baker / Tisch Capital (GP), LLC
Actionnaire important
|
2 411
-2.8%
8,16
19 682 USD
|
2 411
-2.8%
|
8,16
|
19 682 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
142 827
-2.1%
8,11
1 157 713 USD
|
142 827
-2.1%
|
8,11
|
1 157 713 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
36 286
-0.5%
8,17
296 504 USD
|
36 286
-0.5%
|
8,17
|
296 504 USD
|
|
|
2009-02-06 |
2009-02-05 |
V
Vente
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
193 252
-2.8%
8,16
1 577 574 USD
|
193 252
-2.8%
|
8,16
|
1 577 574 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Vente
|
14159 capital (GP), LLC
Actionnaire important
|
24 256
-9.6%
8,46
205 191 USD
|
24 256
-9.6%
|
8,46
|
205 191 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Vente
|
14159 capital (GP), LLC
Actionnaire important
|
2 593
-1.0%
8,47
21 961 USD
|
2 593
-1.0%
|
8,47
|
21 961 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Vente
|
14159 capital (GP), LLC
Actionnaire important
|
269
-0.1%
9,03
2 430 USD
|
269
-0.1%
|
9,03
|
2 430 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Vente
|
BAKER JULIAN
Actionnaire important
|
688
-9.6%
8,46
5 820 USD
|
688
-9.6%
|
8,46
|
5 820 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Vente
|
BAKER JULIAN
Actionnaire important
|
74
-1.0%
8,47
627 USD
|
74
-1.0%
|
8,47
|
627 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Vente
|
BAKER JULIAN
Actionnaire important
|
8
-0.1%
9,03
72 USD
|
8
-0.1%
|
9,03
|
72 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Vente
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
256 936
-9.6%
8,46
2 173 524 USD
|
256 936
-9.6%
|
8,46
|
2 173 524 USD
|
|
|
2009-02-06 |
2009-02-04 |
V
Vente
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
27 485
-1.1%
8,47
232 781 USD
|
27 485
-1.1%
|
8,47
|
232 781 USD
|
|
